R Michael Carruthers - Net Worth and Insider Trading
R Michael Carruthers Net Worth
The estimated net worth of R Michael Carruthers is at least $1 Million dollars as of 2024-05-21. R Michael Carruthers is the CFO of Edgewise Therapeutics Inc and owns about 35,230 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $630,265. R Michael Carruthers is also the Exec Vice President / CFO of Alpine Immune Sciences Inc and owns about 6,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $389,820. Details can be seen in R Michael Carruthers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Michael Carruthers has not made any transactions after 2024-05-02 and currently still holds the listed stock(s).
Transaction Summary of R Michael Carruthers
R Michael Carruthers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Michael Carruthers owns 4 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Alpine Immune Sciences Inc (ALPN) , and Edgewise Therapeutics Inc (EWTX) among others .
Click here to see the complete history of R Michael Carruthers’s form 4 insider trades.
Insider Ownership Summary of R Michael Carruthers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | Chief Financial Officer |
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | Chief Financial Officer |
| EWTX | Edgewise Therapeutics Inc | 2024-05-02 | Chief Financial Officer |
 | | 2021-06-24 | director |
R Michael Carruthers Latest Holdings Summary
R Michael Carruthers currently owns a total of 2 stocks. Among these stocks, R Michael Carruthers owns 35,230 shares of Edgewise Therapeutics Inc (EWTX) as of May 2, 2024, with a value of $630,265 and a weighting of 61.79%. R Michael Carruthers also owns 6,000 shares of Alpine Immune Sciences Inc (ALPN) as of December 2, 2016, with a value of $389,820 and a weighting of 38.21%.
Latest Holdings of R Michael Carruthers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics Inc | 2024-05-02 | 35,230 | 17.89 | 630,265 |
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | 6,000 | 64.97 | 389,820 |
Holding Weightings of R Michael Carruthers
R Michael Carruthers Form 4 Trading Tracker
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 3 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 2,157 shares on May 2, 2024, which brought R Michael Carruthers around $40,789.
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 6,000 shares on December 2, 2016, which cost R Michael Carruthers around $50,160.
Insider Trading History of R Michael Carruthers
- 1
R Michael Carruthers Trading Performance
GuruFocus tracks the stock performance after each of R Michael Carruthers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Michael Carruthers is 32.85%. GuruFocus also compares R Michael Carruthers's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Michael Carruthers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Michael Carruthers's insider trading performs compared to the benchmark.
Performance of R Michael Carruthers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.21 | | | | | |
| Relative Return to S&P 500(%) | 6.07 | | | | | |
R Michael Carruthers Ownership Network
R Michael Carruthers Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
R Michael Carruthers is the Chief Financial Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, R Michael Carruthers made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 450,589 shares, with a net purchase of 450,589 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 647,589 shares were bought by its insiders, resulting in a net purchase of 647,479 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
R Michael Carruthers Mailing Address
Above is the net worth, insider trading, and ownership report for R Michael Carruthers. You might contact R Michael Carruthers via mailing address: 3122 Sterling Circle, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
